Sign in Subscribe
Class action lawsuits

Securities Class Action Lawsuit Filed Against Alto Neuroscience, Inc.

Strategic Insights

— 1 min read

A shareholder has filed a securities class action lawsuit on behalf of investors who purchased or acquired Alto Neuroscience, Inc. common stock in connection with the company's initial public offering (IPO) conducted on February 2, 2024, or between February 2, 2024, and October 22, 2024. The lawsuit alleges that defendants made misrepresentations concerning the clinical, regulatory, and commercial prospects of ALTO-100, a drug developed for the treatment of patients with major depressive disorder.

Key Takeaways:

  • The class action lawsuit was filed on behalf of investors who purchased or acquired Alto Neuroscience, Inc. common stock in connection with the company's IPO or between February 2, 2024, and October 22, 2024.
  • The lawsuit alleges that defendants made misrepresentations concerning the clinical, regulatory, and commercial prospects of ALTO-100, a drug developed for the treatment of patients with major depressive disorder.
  • The plaintiff alleges that Alto Neuroscience, Inc. and its executives violated the Securities Exchange Act of 1934.
  • The lawsuit seeks to recover damages for investors who suffered losses due to the alleged misrepresentations.
  • The law firm responsible for the advertising, Bernstein Liebhard LLP, has a history of recovering over $3.5 billion for its clients since 1993.
  • The firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years.

Statistics:

  • The class action lawsuit alleges that Alto Neuroscience, Inc. and its executives made misrepresentations about the clinical, regulatory, and commercial prospects of ALTO-100.
  • The lawsuit seeks to recover damages for investors who suffered losses due to the alleged misrepresentations.
  • Bernstein Liebhard LLP has recovered over $3.5 billion for its clients since 1993.
  • The firm has been successful in litigating hundreds of class actions, resulting in the National Law Journal's "Plaintiffs' Hot List" recognition thirteen times.
  • The firm has been listed in The Legal 500 for sixteen consecutive years.

Sources:

  • Bernie Liebhard LLP, "Securities Class Action Lawsuit Filed Against Alto Neuroscience, Inc.," August 18, 2025.
  • SEC, "Securities Exchange Act of 1934," 15 U.S.C. 78a et seq.
  • National Law Journal, "Plaintiffs' Hot List," 2020.
  • Legal 500, "United States - Class Action Defendants: Counsel Firms," 2020.

Read more